Mira

What Mira does

Mira (legal entity Quanovate Tech Inc.) is a U.S.-based women's hormonal health company founded in 2015 by Sylvia Kang, a biomedical engineer, and co-founder Zheng Yang, headquartered in San Ramon, California. The company sells a proprietary at-home hormone monitoring platform built on fluorescent immunoassay technology, which delivers lab-quality quantitative measurement of multiple reproductive hormones (LH, E3G, PdG, and on the flagship Ultra4 also FSH) via swappable single-use test wands read by a connected monitor device, with results delivered in approximately 16 minutes at claimed 99% accuracy. The system is paired with the Mira mobile application (iOS/Android) and an AI layer trained on a proprietary dataset of more than 1.7 million real cycles and 30 million hormone data points, which produces personalized ovulation prediction, cycle insights, and support for irregular cycles, PCOS, and perimenopause.

The business operates a razor/blade model: a one-time hardware purchase (Ultra4 Kit at $249, plus Max and Basic kit tiers) anchors the customer, and recurring revenue comes from consumable wand packs (e.g., $99 for 20 Ultra4 Wands, with active cyclers using 10-20 wands per cycle), auto-renew subscriptions, supplements, at-home lab tests, and 1:1 certified hormone health consultations. Distribution is primarily direct-to-consumer through an owned Shopify storefront with warehouses in the USA, UK, France, Netherlands, China, and Australia shipping to 115 countries, supplemented by the Carrot Collective enterprise marketplace, a corporate benefits sales motion (e.g., Twic), and a healthcare-professional referral network of 3,000+ providers and 50+ university/clinic research partnerships. The product portfolio has been extended beyond core fertility tracking into the Menopause Transitions Kit (October 2024), an integrative hormone health clinic (July 2024), and an Oura Ring integration (February 2026). The company is FDA-listed and CE-certified, was named America's fastest-growing femtech in 2023 with 1,323% three-year revenue growth, and has cumulatively reported 30,000 pregnancies among its 250,000+ users.

Name

Mira

Legal name

Quanovate Tech Inc.

Website

https://miracare.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

101–250 employees

Short description

Mira (Quanovate Tech Inc.) is a U.S. femtech company selling an FDA-listed, CE-certified at-home hormone monitoring platform using fluorescent immunoassay technology, paired with an AI app trained on 1.7M+ cycles. It sells directly to consumers and through enterprise fertility benefits, serving women trying to conceive, those with PCOS or irregular cycles, and perimenopausal women.

Ownership category

akta.pro rank

Product category

At-Home Hormone Monitoring Devices

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical and Diagnostic Laboratories (62151)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)

akta.pro secondary industries

Home-Use & OTC Rapid Self-Tests (Consumer POCT kits) (HLAHAOAK), Women’s Health & Fertility Tracking Devices (Ovulation/Temp Sensors, Pelvic Health Devices) (CRACAQAJ), Maternal & High-Risk Pregnancy Remote Monitoring (BP, glucose, fetal/uterine monitoring) (HLALAFAG), Fertility & Ovulation Products (OTC) (CRABAIAK), Women’s Health & Fertility Therapeutics (Digital) (HLACANAK)

Keywords

• At-home hormone monitoring
• Fertility tracking devices
• Women's health technology
• Lab-quality hormone testing
• Cycle and ovulation tracking

Headquarters

HQ city

Pleasanton

HQ country

United States

HQ region

North America

Offices7 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Marketing or Sales, Operations, Personnel

Revenue model

1. Hardware Sales - Hormone Monitors: One-time purchase of hormone monitoring devices (Ultra4 Kit at $249). Includes monitor and wands. Device provides lab-quality hormone testing using fluorescent immunoassay technology.
2. Consumables - Hormone Test Wands: Recurring consumable revenue from test wands. Multiple wand types available (Ultra4 Wands, Max Wands, Plus Wands, Ovum Wands, Confirm Wands). Typically 10-20 wands needed per cycle for consistent tracking.
3. Subscription Services: Subscription model for recurring orders with automatic renewal. Subscribers receive scheduled wand deliveries with potential discounts. Financing options available for kit purchases.
4. Expert Consultations: 1:1 virtual consultations with certified hormone health coaches for fertility support and menopause guidance. Part of integrative hormone health clinic services.
5. Supplements: Fertility support supplements including Prenatal Multi-Vitamins, PCOS Supplements, and Fertility Tea for complementary revenue.
6. Lab Tests: Panorama Fertility Lab Test - at-home blood test for 5 key hormones. Male Fertility Kit for sperm analysis.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Core offering

Mira sells FDA-listed and CE-certified at-home hormone monitoring hardware kits (Ultra4, Max, Basic) paired with swappable test wands that quantify fertility hormones (LH, E3G, PdG, FSH) using fluorescent immunoassay technology. The offering is completed by a companion AI-powered mobile app for personalized cycle insights, recurring wand subscriptions, supplements, at-home lab tests, male fertility tests, and 1:1 certified hormone health consultations for fertility and menopause support.

Product overview

Mira is a women's hormonal health company offering a comprehensive at-home hormone monitoring ecosystem. The core product portfolio centers on the Mira Hormone Monitor hardware platform with swappable test wands (Ultra4, Max, Plus, Ovum, and Confirm) that measure various hormone combinations (LH, E3G, PdG, FSH). The system includes companion kits for fertility (Ultra4 Kit, Max Kit, Basic Kit), perimenopause management (Ultra4 Kit for Perimenopause), and male fertility testing. The Mira App serves as the central platform, providing AI-powered cycle analysis, personalized fertility predictions, and biometric data integration. The company also offers supplements (Prenatal Multi-Vitamins, PCOS Supplements, Fertility Tea), clinical consultations (1:1 Certified Fertility Support, 1:1 Certified Menopause Support), at-home lab tests (Panorama Fertility Lab Test), and bundled offerings for couples and pregnancy planning.

Differentiator

Problem solved

Functional benefit

Products and services

• Ultra4 Kit All-in-one at-home hormone monitoring kit that uses 4-in-1 multi-hormone testing to measure LH, E3G, PdG, and FSH in 16 minutes with 99% lab-quality accuracy; intended for women tracking fertility, PCOS, or perimenopause.
• Ultra4 Kit for Perimenopause Hormone monitoring kit built on the Ultra4 platform with a dedicated Menopause Mode for tracking hormonal fluctuations during perimenopause; targets women navigating the menopause transition.
• Max Kit

Quantifiable outcome

• 84% of women got pregnant within their first 6 cycles of using Mira
• +3 more outcomes

Named customers1 record

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability2 records

Feature4 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• FLO LivingcoreStrategic or Co-development Partner · 10 March 2026Clinical study collaboration demonstrating that Cycle Syncing Method significantly reduces PMS symptoms. Study conducted with FLO Living, Mira, Hello Inside, and Citruslabs involving 60 women over three months.
• Hello InsideminorStrategic or Co-development Partner · 10 March 2026Co-development partner in clinical study on Cycle Syncing Method for PMS symptom reduction.
• CitruslabsminorStrategic or Co-development Partner · 10 March 2026Clinical research partner conducting study on Cycle Syncing Method with Mira and other femtech companies.
• ŌURAcoreTechnology or Integration · 10 February 2026Direct integration allowing Mira users to view Oura Ring's sleep, readiness, and temperature trends alongside their hormone data within the Mira app. Enables correlation of hormonal fluctuations with daily biometric signals across fertility, perimenopause, and hormonal imbalance use cases.
• CarrotcoreGTM or Marketing Partner · 5 December 2025Mira products featured in Carrot Collective marketplace offering clinically vetted fertility and hormonal health products to Carrot members globally at no additional cost to employers.
• FLO LivingcoreStrategic or Co-development Partner · 18 July 2025FLO Living won Mira's inaugural Hormone Innovators Award for Cycle Syncing Method, recognizing pioneers in hormonal and reproductive health to commemorate the 120th anniversary of hormone discovery.
• Ali RileyminorGTM or Marketing Partner · 6 May 2025Partnership with professional soccer star Ali Riley to promote women's hormonal health. Riley shares her personal IVF journey using Mira's hormone tracking technology for empowerment and awareness.

Scale indicators11 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• Flo Health: Flo Health operates the Flo app, a leading women's health and period tracker with AI-driven predictions. It competes with Mira on consumer cycle-tracking mindshare and has expanded into insights and premium subscriptions.
• Clue: Clue is one of the most widely used period and ovulation tracking apps globally. It overlaps with Mira's cycle-prediction and consumer-women's-health segments and is also a fellow partner in Oura's women's health ecosystem.
• Natural Cycles: Natural Cycles is an FDA-cleared digital fertility tracking app that uses basal body temperature to identify the fertile window. It directly competes with Mira on hormone-based, app-driven conception and contraception use cases for the same target consumer.
• Premom: Premom offers app-based ovulation prediction paired with affordable LH test strips and quantitative readers. It competes with Mira on the lower-priced ovulation-tracking end and shares an app-driven, hormone-data approach.
• Tempdrop: Tempdrop is a wearable basal body temperature sensor for fertility tracking. It overlaps with Mira on automated, sensor-based temperature and cycle tracking, particularly for women with irregular cycles or shift-based sleep patterns.
• Ava: Ava is a fertility tracking bracelet that combines physiological sensors with cycle prediction software. It competes directly with Mira in the wearables-meets-hormone-tracking category for women trying to conceive.
• Modern Fertility (Ro): Modern Fertility (acquired by Ro) offers at-home hormone testing kits and a digital platform targeting the same women's reproductive health and fertility planning segments as Mira, with strong consumer brand presence in the U.S.

Emerging players

• Elvie: Elvie develops connected women's health hardware (pelvic floor trainers, breast pumps) for the same premium, design-conscious consumer demographic as Mira and is expanding into broader femtech health monitoring.
• Oura: Oura is Mira's biometric integration partner but also a competitive wearable for women's health insights (temperature trends, cycle insights). Overlap exists in cycle-pattern tracking and premium consumer health positioning.

Broad incumbents

• Clearblue (Swiss Precision Diagnostics): Clearblue is the incumbent consumer ovulation and pregnancy test brand, offering colorimetric OPKs and digital monitors. It competes with Mira in at-home ovulation testing and benefits from broad retail distribution and brand recognition.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/mirafertility
• YouTubeyoutube.com/channel/UCS5Z-P55EpyB-eAnwZsvOdg
• Facebookfacebook.com/mirafertility
• LinkedInlinkedin.com/company/miracare
• Instagraminstagram.com/hellomiracare
• TikToktiktok.com/@hellomiracare
• Pinterestpinterest.com/mirafertility

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds3 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mira